Communities across Australia rely on Registered Nurses (RNs) to provide primary care, acute care and aged care. They are skilled, capable and trusted healthcare practitioners often working in some of the most rural and remote parts of the country.
In March 2023, the Australian Government released the National Rural and Remote Nursing Generalist Framework 2023–2027. The Framework is a world first and describes the unique context of practice and core capabilities for rural and remote Registered Nurses in Australia.
As well as describing skills, capabilities and support needed by RNs, the Framework emphasises the importance of clinical decision-making judgement of the patient’s situation, culturally safe practice, collaboration, and partnerships with clients, families and communities.
The framework is for RNs who work in rural and remote locations across Australia, or are looking to relocate there. One such nurse who relocated is Clinton Archer, with Queensland Health, who was interviewed by Australian Health Journal for this segment.
Other ways the the Framework can be applied include:
- For Registered Nurses, mapping their development of the capabilities with a mentor, to develop from formative to proficient skill levels.
- For Educators and Education Providers, supporting individual skill development or curriculum based on the capabilities.
- Government, Organisations and Employers, using the Framework as a guide to grow and support the development of a skilled rural and remote RN workforce
The Framework was developed by the Office of the National Rural Health Commissioner and Australian Health Journal spoke with National Rural Health Commissioner, Adjunct Professor Ruth Stewart, and Deputy National Rural Health Commissioner – Nursing and Midwifery, Adjunct Professor Shelley Nowlan, on the importance of rural and remote nursing and of the Framework itself.
Important contributions and expertise of the members of the National Rural and Remote Nursing Generalist Framework Steering Committee (Steering Committee) led the Framework through its development and consultation. Steering Committee members represented the following organisations.
- Office of the National Rural Health Commissioner
- Australian Government Department of Health and Aged Care
- Australian and New Zealand Council of Chief Nursing and Midwifery Officers
- Australian College of Nurse Practitioners (ACNP)
- Australian College of Nursing (ACN)
- Australian Nursing and Midwifery Accreditation Council (ANMAC)
- Australian Nursing and Midwifery Federation (ANMF)
- Australian Primary Health Care Nurses Association (APNA)
- Congress of Aboriginal and Torres Strait Islander Nurses and Midwives (CATSINaM)
- Council of Deans of Nursing and Midwifery (CDNM)
- Council of Remote Area Nurses of Australia (CRANAplus)
- James Cook University
- Nursing and Midwifery Board of Australia (NMBA)
-
Integrating oral health care across non-dental professionals
Poor oral health can contribute to or exacerbate several systemic health conditions due to the close connection between oral bacteria, inflammation, and systemic processes. These conditions include cardiovascular health, diabetes, respiratory health, cognitive health, pregnancy and birth outcomes.
-
Bionic eye trial shows improvements in functional vision for retinitis pigmentosa
Results of the first clinical trial of Australia’s ‘second generation’ bionic eye have demonstrated ‘substantial improvement’ in four participants’ functional vision, daily activities and quality of life over a period of more than two and a half years.
Led by the Centre for Eye Research Australia, Bionics Institute, University of Melbourne and Royal Victorian Eye and Ear Hospital, the trial findings add to interim results which showed that the second-generation bionic eye developed by Australian company Bionic Vision Technologies provided rapid improvements for four patients with blindness caused the genetic eye condition retinitis pigmentosa.
-
New option for management of high-risk soft tissue sarcoma of the limb
SARC032 is the first completed randomised clinical trial of its kind and has demonstrated compelling evidence to integrate immunotherapy, with the standard treatment regimen of radiotherapy and surgery for patients with grade 2 or 3, stage III soft tissue sarcoma of the limb.
